Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sheryl Spithoff is active.

Publication


Featured researches published by Sheryl Spithoff.


Canadian Medical Association Journal | 2015

Cannabis legalization: adhering to public health best practice

Sheryl Spithoff; Brian Emerson; Andrea Spithoff

According to the 2011 United Nations World Drug Report, the prevalence of cannabis use in the Netherlands, where cannabis has been de facto legal for the last 40 years, is lower than in many other European countries, the United States and Canada.[1][1] Jurisdictions that have recently legalized


Drug and Alcohol Dependence | 2017

Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014

Qi Guan; Wayne Khuu; Sheryl Spithoff; Tara Kiran; Meldon Kahan; Mina Tadrous; Diana Martins; Pamela Leece; Tara Gomes

BACKGROUND Despite concerns surrounding high patient volumes in methadone clinics, little is known about the practice patterns of opioid maintenance therapy (OMT) providers in Ontario. We examined the distribution of these services and how physician characteristics differ based on prescribing volume. METHODS We conducted a cross-sectional study among prescribers of methadone or buprenorphine to Ontario public drug beneficiaries in 2014 by stratifying physicians into low- (lower 50%), moderate- (51-89%) and high-volume (top 10%) prescribers. We summarized the distribution of OMT prescription days dispensed and urine drug screens (UDS) ordered using Lorenz curves and examined physician characteristics using descriptive statistics. RESULTS We identified 893 OMT prescribers in 2014. Physicians were mostly male (67.5%; N=603), and middle-aged (median was 50). High-volume methadone providers (N=57) prescribed approximately 56% (N=4,115,322) of the total days of methadone (Gini coefficient=0.76, 95% CI 0.74-0.79) while high-volume buprenorphine providers (N=64) prescribed 61% (N=589,463) of the total days of buprenorphine (Gini coefficient=0.78, 95% CI 0.75-0.80). On average, each high-volume methadone prescriber treated 435 OMT patients and billed 43 UDS per patient, while each high-volume buprenorphine prescriber treated 64 OMT patients and billed 22 UDS per patient. Daily OMT patient volume was on average 74 for high-volume methadone prescribers and 6 for high-volume buprenorphine prescribers. CONCLUSIONS OMT services are highly concentrated among a small portion of OMT providers who carry high daily patient volumes. Future research should examine the quality of primary care received by their patients to better elucidate the possible consequences of this highly unequal distribution of services.


Canadian Medical Association Journal | 2015

A systemic failure to address at-risk drinking and alcohol use disorders: the Canadian story

Sheryl Spithoff; Suzanne Turner

See also page [502][1] and [www.cmaj.ca/lookup/doi/10.1503/cmaj.140254][2] Alcohol use disorders, defined as clinically significant impairment or distress from the use of alcohol, are common in Canadian society.[1][3] In addition, 15% to 20% of Canadians who do not meet the criteria for an alcohol


Canadian Family Physician | 2014

Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations.

Meldon Kahan; Anita Srivastava; Sheryl Spithoff; Lisa Bromley


Canadian Family Physician | 2014

Industry involvement in continuing medical education: time to say no.

Sheryl Spithoff


Canadian Family Physician | 2015

Primary care management of alcohol use disorder and at-risk drinking: Part 2: counsel, prescribe, connect.

Sheryl Spithoff; Meldon Kahan


Canadian Family Physician | 2015

Primary care management of alcohol use disorder and at-risk drinking: Part 1: screening and assessment

Sheryl Spithoff; Meldon Kahan


Canadian Family Physician | 2014

Approach to cannabis use disorder in primary care Focus on youth and other high-risk users

Suzanne Turner; Sheryl Spithoff; Meldon Kahan


Canadian Family Physician | 2015

Paradigm shift: Moving the management of alcohol use disorders from specialized care to primary care.

Sheryl Spithoff; Meldon Kahan


Canadian Family Physician | 2014

Cannabis and Canadian youth: Evidence, not ideology

Sheryl Spithoff; Meldon Kahan

Collaboration


Dive into the Sheryl Spithoff's collaboration.

Top Co-Authors

Avatar

Meldon Kahan

Women's College Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Qi Guan

University of Toronto

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge